To order this detailed 600+ page report, please visit this https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html
Key Inclusions
§
An overview of the
current market landscape of companies engaged in developing and / or
manufacturing autoinjectors, providing information on the usability (disposable
and reusable), type of primary drug container (cartridge, syringe and vial),
volume of container, type of dose (fixed and variable), route of administration
(intradermal, intramuscular and subcutaneous), actuation mechanism (automatic
and manual) and feedback mechanism integrated in the device. It also provides
details on the developers, highlighting their year of establishment, company
size (small-sized, mid-sized and large), location of headquarters and location
of manufacturing facilities
§
Information on companies
that are developing drugs in combination with autoinjectors, featuring details
on initial year of approval (for marketed products), phase of development,
usability of the device, route of administration (intracavernous, intramuscular
and subcutaneous), type of drug molecule (antibody, peptide, protein and small
molecule), dose strength, therapeutic area and other approved dosage forms (for
marketed products). In addition, the section provides details on the company,
including year of establishment, company size and location of headquarters
§
A competitiveness
analysis of various disposable and reusable autoinjectors, taking into
consideration supplier power (based on year of establishment and company size)
and key product specifications, such as route of administration, primary drug
container used, injector actuation mechanism, type of dose and user
friendliness of the product.
§
An in-depth analysis
of the various patents that have been filed / granted related to autoinjectors,
till August 2019, highlighting details on key parameters, such as type of
patent, publication year, issuing authority, CPC classification, emerging focus
areas and leading industry players (on the basis of number of patents). It also
includes a detailed patent benchmarking and an insightful valuation analysis.
§
A detailed brand
positioning analysis of leading industry players (shortlisted on the basis of
strength of product portfolio), highlighting the current perceptions regarding
their proprietary brands by taking into consideration several relevant aspects,
such as strength and diversity of product portfolio, route of administration,
actuation mechanism, geographical presence / reach and supplier power of each
company.
§
A list of marketed
drugs / therapies and pipeline candidates that are likely to be developed in
combination with autoinjectors in the near future, shortlisted on the basis of
an in-depth analysis that takes into consideration various relevant parameters,
such as route of administration, type of drug molecule, target indications,
other available dosage forms (for approved drugs) and historical annual sales
information (for approved drugs).
§
A list of key opinion
leaders (KOLs) within this domain who were short-listed based on their
contributions (such as involvement in clinical trials and being mentioned in
patent applications); it features a schematic world map representation,
highlighting the geographical locations of eminent scientists / researchers
engaged in this domain.
§
Detailed case studies
on the most commonly targeted indications, covering history of development and
detailed description of the approved autoinjector products, along with their
respective mechanisms of action and historical sales records; the study
provides a list of all the drugs that are currently being delivered via
autoinjectors.
§
A case study on the
role of CMOs offering services for drug delivery devices; it features a list of
service providers, highlighting the various types of services offered for
different types of drug-delivery devices.
§
A SWOT analysis
capturing the key parameters and trends that are likely to influence the future
of autoinjectors market.
§
Elaborate profiles of
autoinjector manufacturers that have more than three devices in their
respective product portfolios; each profile features an overview of the
company, its financial information (if available), information on its product
portfolio, autoinjector device specifications, collaborations, recent
developments and an informed future outlook. Additionally, the report includes
brief profiles of emerging players that have been established in the past
decade.
The report also
features the likely distribution of the current and forecasted opportunity
across important market segments, mentioned below:
§
Usability
§
Disposable
§
Reusable
§
Route of administration
§
Subcutaneous
§
Intramuscular
§
Type of molecule
§
Antibody
§
Peptide
§
Protein
§
Small molecule
§
Therapeutic indication
§
Anaphylaxis
§
Diabetes
§
Migraine
§
Multiple sclerosis
§
Rheumatoid arthritis
§
Other indications
§
Key geographical regions
§
North America
§
Europe
§
Asia-Pacific
§
Rest of the World
The report features
inputs from eminent industry stakeholders, according to whom autoinjectors
address several limitations of conventional parenteral drug delivery process,
by preventing accidental needle-stick injuries, dosing errors and are preferred
even by patients with trypanophobia. The report includes detailed
transcripts of discussions held with the following experts:
§ David Daily (Chief
Executive Officer and Co-founder, DALI Medical Devices)
§ Dennis Lee (Senior
Program Officer in CMC, Bill & Melinda Gates Foundation)
§ Douglas Marenzi
(Managing Director, PHC Injection Technologies)
§ Tsachi Shaked (Senior
Marketing and BD Director, Injectable Drug Delivery Devices, Elcam Medical)
§ Anonymous (Design
Director, US-based Large Company)
To request sample pages, please visit this - https://www.rootsanalysis.com/reports/293/request-sample.html
Key Questions Answered
§ Who are the leading autoinjector device
developers?
§ For which disease indications are
autoinjector-based combination products available?
§ What is the relative product competitiveness of
autoinjectors (based on user friendliness, type of dosage, route of
administration and type of primary drug container)?
§ Which drug candidates are likely to be considered
for administration via autoinjectors in near future?
§ How the intellectual property landscape likely to
evolve in the foreseen future?
§ Who are the Key Opinion Leaders across different
regions worldwide?
§ Who are the leading contract manufacturing
organizations active in this field? What is their relative brand positioning?
§ What is share of autoinjector devices, in terms
of revenue generation potential, across different disease markets?
§ How is the current and future opportunity likely
to be distributed across key market segments?
You may also be interested in the following titles:
1. Prefilled
Syringes Market (5th Edition), 2019-2030
2. Novel
Vaccine Delivery Devices Market, 2019-2030
3. Microneedles
and Needle-Free Injection Systems / Jet Injectors (Devices
based on Spring, Gas and Other Mechanisms) Market, 2019-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
